Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome. (2017)

First Author: Till KJ
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-17021-w

PubMed Identifier: 29196709

Publication URI: http://europepmc.org/abstract/MED/29196709

Type: Journal Article/Review

Volume: 7

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322